INVZ vs. DNA
Compare and contrast key facts about Innoviz Technologies Ltd. (INVZ) and Ginkgo Bioworks Holdings, Inc. (DNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: INVZ or DNA.
Performance
INVZ vs. DNA - Performance Comparison
Returns By Period
In the year-to-date period, INVZ achieves a -79.05% return, which is significantly higher than DNA's -90.25% return.
INVZ
-79.05%
-32.05%
-50.93%
-72.40%
N/A
N/A
DNA
-90.25%
-29.74%
-74.90%
-88.06%
N/A
N/A
Fundamentals
| INVZ | DNA | |
|---|---|---|
| Market Cap | $91.11M | $370.74M |
| EPS | -$0.64 | -$12.89 |
| Total Revenue (TTM) | $20.39M | $217.95M |
| Gross Profit (TTM) | -$1.77M | $138.89M |
| EBITDA (TTM) | -$74.42M | -$626.41M |
Key characteristics
| INVZ | DNA | |
|---|---|---|
| Sharpe Ratio | -0.89 | -0.89 |
| Sortino Ratio | -1.87 | -2.22 |
| Omega Ratio | 0.81 | 0.76 |
| Calmar Ratio | -0.75 | -0.89 |
| Martin Ratio | -1.20 | -1.37 |
| Ulcer Index | 60.41% | 64.65% |
| Daily Std Dev | 81.37% | 99.09% |
| Max Drawdown | -96.06% | -99.10% |
| Current Drawdown | -95.71% | -98.90% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between INVZ and DNA is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
INVZ vs. DNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Innoviz Technologies Ltd. (INVZ) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
INVZ vs. DNA - Dividend Comparison
Neither INVZ nor DNA has paid dividends to shareholders.
Drawdowns
INVZ vs. DNA - Drawdown Comparison
The maximum INVZ drawdown since its inception was -96.06%, roughly equal to the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for INVZ and DNA. For additional features, visit the drawdowns tool.
Volatility
INVZ vs. DNA - Volatility Comparison
The current volatility for Innoviz Technologies Ltd. (INVZ) is 24.99%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 27.24%. This indicates that INVZ experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
INVZ vs. DNA - Financials Comparison
This section allows you to compare key financial metrics between Innoviz Technologies Ltd. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities